Advertisement

ANGO

AngioDynamics, Inc.

Healthcare · USD

Set alert

Price alert · ANGO

All alert types
11.99 USD -0.36 -2.91%
As of Oct 30, 2026 Extended hours 11.99 0.00%
Bid
11.99 × 2
Ask
12.00 × 2
11.89 Day range 12.34
9.70 52-week range 16.13
YTD
-6.62%
1 year
-1.24%
Open
12.32
Prev close
12.35
Mkt cap
504.23M
Vol
475.83K
Avg vol
643.04K
EPS
-0.78
P/E
0.00
Div yield
0.00%
More statistics
Low
11.89
High
12.34
Forward P/E
-36.21
Beta
0.67
Short ratio
2.88
Inst. own
81.31%
Dividend
0.00
Ex-div date
Earnings
Jan 8, 2025
50-d avg
7.35
200-d avg
6.77
1y target
13.00

3M chart

Chart tools
Interval
ANGO three-month price chart10.612.013.514.916.3Jul 31Aug 19Sep 8Sep 24Oct 13Oct 30

Key statistics

Market cap
353.11M
Enterprise value
311.65M
Trailing P/E
0.00
Forward P/E
-36.21
PEG ratio
0.00
Price / sales
1.21
Price / book
1.81
EPS (TTM)
-6.05
Beta
0.67
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-83.02%
Revenue (TTM)
292.73M
Revenue growth
-14.20%
Free cash flow
24.19M
Total cash
55.01M
Total debt
5.42M
Return on equity
-77.85%
Shares outstanding
40.63M
Short % of float
3.42%
50-day average
7.35
200-day average
6.77

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 13.00 +8.4% upside
Target (low)
12.00
Target (mean)
13.00
Target (high)
14.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Jan 8, 2025

Expected Jan 8, 2025. Consensus EPS estimate -0.11.

Earnings history

Financials — quick view

All financials
ANGO Revenue — quarterly 80.92M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
ANGO Net income — quarterly -7.10M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
ANGO EPS — quarterly -0.17
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026

Earnings

ANGO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 8, 2025Nov 1, 2024-0.11———
Oct 3, 2024Aug 1, 2024-0.15-0.11+0.04+26.67%
Jul 16, 2024May 1, 2024-0.20-0.06+0.14+70.00%
Apr 4, 2024Feb 1, 2024-0.14-0.16-0.02-14.29%
Jan 5, 2024Nov 1, 2023-0.09-0.05+0.04+44.44%
Oct 4, 2023Aug 1, 2023-0.14-0.12+0.02+14.29%

Upgrades / downgrades

ANGO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024HC Wainwright & Co.reitBuyBuy
Oct 4, 2024HC Wainwright & Co.reitBuyBuy
Oct 4, 2024Canaccord GenuitymainBuyBuy
Sep 20, 2024HC Wainwright & Co.reitBuyBuy
Jul 17, 2024Canaccord GenuitymainBuyBuy
Jul 17, 2024HC Wainwright & Co.reitBuyBuy

About AngioDynamics, Inc.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on ANGO — it syncs with the Stock Master app.

Insider holders

ANGO insider holders
InsiderRelationLatest transactionDateShares held
AUEN EILEEN O SHEADirectorStock Award(Grant)Jul 16, 202487,043
CAMPBELL CHAD THOMASOfficerStock Award(Grant)Jul 16, 202465,366
CLEMMER JAMES CChief Executive OfficerPurchaseOct 6, 2024681,582
DONNELLY HOWARD WDirectorStock Award(Grant)Jul 16, 2024149,376
JOHNSON WESLEY E JRDirectorStock Award(Grant)Jul 16, 2024125,863
LAWRENCE WEISS TOfficerStock Award(Grant)Dec 1, 202452,697

Institution ownership

ANGO institution ownership
Holder% heldSharesValueReported
Blackrock Inc.11.47%4,660,41940.50MSep 29, 2024
Systematic Financial Management, L.P.5.93%2,410,34620.95MSep 29, 2024
Vanguard Group Inc5.64%2,289,85519.90MSep 29, 2024
Millennium Management Llc5.50%2,235,45219.43MSep 29, 2024
Dimensional Fund Advisors LP3.33%1,353,66011.76MSep 29, 2024
Renaissance Technologies, LLC2.60%1,056,8149.18MSep 29, 2024

Fund ownership

ANGO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.95%1,198,94710.42MSep 29, 2024
iShares Russell 2000 ETF2.43%985,5478.56MOct 30, 2024
Vanguard Extended Market Index Fund1.62%659,9585.74MSep 29, 2024
Royce Small-Cap Opportunity Fund1.40%569,4104.95MSep 29, 2024
College Retirement Equities Fund-Stock Account1.15%467,1804.06MSep 29, 2024
Fidelity Small Cap Index Fund0.96%389,3093.38MAug 30, 2024
Advertisement